DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Atopic Dermatitis Treatment Market Analysis: By Type of treatment (Topical Corticosteroids, Immunosuppressant and Others With Forecast (2016-2021)" report to their offering.
Atopic dermatitis is a chronic skin inflammation that is mostly seen in infants of age 2-3 months and above to children under 5 years of age. However, there are cases of this affecting adults as well. A skin disease that lasts for long, atopic dermatitis is associated with itchiness, redness of skin and cracked skin.
While the causes till date remain unknown, it is said that people who have atopic dermatitis tend to develop hay fever and asthma. Atopic dermatitis is believed to be a genetic problem. There is also a common belief that environmental conditions can make potentially susceptible individuals more likely to get atopic dermatitis. Other factors include seasonal allergies, varying humidity levels, extreme climatic conditions and reaction to strong detergents.
Apart from the growing population that is driving the growth of the atopic dermatitis treatment market, factors such as climatic changes and rising pollution levels are also fuelling the growth of this market. A significant amount of research and development efforts by research institutes and pharmaceutical companies alike is leading to the development of new drugs to deal with this condition. The use of biologics and biomarkers in the treatment of atopic dermatitis is one such development.
- Regeneron Pharmaceuticals Inc.
- Astellas Pharma
- Anacor Pharmaceuticals Inc.
- Meda AB
1. Atopic Dermatitis Treatment Market Overview
2. Executive Summary
3. Atopic Dermatitis Treatment Market Landscape
4. Atopic Dermatitis Treatment Market Forces
5. Atopic Dermatitis Treatment Market - Strategic Analysis
6. Atopic Dermatitis Treatment Market By Type of Treatment
7. Atopic Dermatitis Treatment Market By Geography
8. Atopic Dermatitis Treatment Market Entropy
9. Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/mvb2wv/atopic_dermatitis